Despite Regulatory Uncertainties, HCA Healthcare Looks Healthy

  • I believe HCA Healthcare is currently undervalued, especially after a recent 20.9% share price drop, making it a compelling 'buy' candidate. HCA Healthcare's financial performance has been solid, with revenue rising 5.7% year-over-year, driven by increased hospital traffic and higher revenue per admission. Despite mixed profitability metrics, management's forecast for 2025 shows expected revenue growth and higher profits, reinforcing my bullish stance.